Latest filing published 06 May 2022 for Acerus Pharmaceuticals Corporation.
No signal scores available.
All filings by Borys Chabursky on record concern Acerus Pharmaceuticals Corporation. We count 3 filings; the first trade dates from 13 November 2020 and the latest from 6 May 2022.
The open-market record is one-sided, with 1 purchase worth €7,735 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 6 May 2022 with a transaction in Acerus Pharmaceuticals Corporation. The clock since the last published purchase (16 November 2020) now reads 2,170 days. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations